{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:17:02Z","timestamp":1786990622805,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ijid.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T20:55:40Z","timestamp":1678481740000},"page":"147-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"130","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8815-0780","authenticated-orcid":false,"given":"Honglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1130-4689","authenticated-orcid":false,"given":"Zhiqiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.03.011_bib0001","unstructured":"World Health Organization. Director General's opening remarks at the media briefing on COVID-19, https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-20-march-2020; 2020 [accessed 22 November 2022]."},{"key":"10.1016\/j.ijid.2023.03.011_bib0002","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2023.03.011_bib0003","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0004","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2023.03.011_bib0005","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2023.03.011_bib0006","article-title":"Critical Determinants of cytokine Storm and Type I interferon Response in COVID-19 pathogenesis","volume":"34","author":"Ramasamy","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2023.03.011_bib0007","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijid.2023.03.011_bib0008","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","volume":"99","author":"Abers","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0009","doi-asserted-by":"crossref","first-page":"eabh2624","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2023.03.011_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.comppsych.2015.05.001","article-title":"Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies","volume":"61","author":"Hu","year":"2015","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.ijid.2023.03.011_bib0011","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/eji.202249824","article-title":"Anti-IFN-\u03b1\/-\u03c9 neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity","volume":"52","author":"Frasca","year":"2022","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0012","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10875-022-01252-2","article-title":"Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies","volume":"42","author":"Akbil","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0013","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s10875-022-01308-3","article-title":"Neutralizing Type I interferon autoantibodies in Japanese patients with severe COVID-19","volume":"42","author":"Eto","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab466.649","article-title":"Type-I interferon autoantibodies are detected in those with critical COVID-19, including a young female patient","volume":"8","author":"Yee","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.011_bib0015","doi-asserted-by":"crossref","first-page":"eabl4340","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0016","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.ijid.2023.03.011_bib0017","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.3390\/ijms22168965","article-title":"Adaptive immunity and the risk of autoreactivity in COVID-19","volume":"22","author":"Moody","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2023.03.011_bib0018","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/cts.12953","article-title":"SARS-CoV-2 infection as a trigger of autoimmune response","volume":"14","author":"Sacchi","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ijid.2023.03.011_bib0019","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/all.15302","article-title":"Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures","volume":"77","author":"Taeschler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.ijid.2023.03.011_bib0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-020-02180-0","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.ijid.2023.03.011_bib0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/iid3.109","article-title":"IL-6-specific autoantibodies among APECED and thymoma patients","volume":"4","author":"K\u00e4rner","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.ijid.2023.03.011_bib0022","first-page":"14","article-title":"Life-threatening COVID-19: defective interferons unleash excessive inflammation","volume":"1","author":"Zhang","year":"2020","journal-title":"Med (N Y)"},{"key":"10.1016\/j.ijid.2023.03.011_bib0023","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijid.2023.03.011_bib0024","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","volume":"131","author":"Meisel","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2023.03.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102743","article-title":"An updated advance of autoantibodies in autoimmune diseases","volume":"20","author":"Xiao","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijid.2023.03.011_bib0026","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10875-021-01203-3","article-title":"Autoantibodies neutralizing Type I interferons in 20% of COVID-19 deaths in a French hospital","volume":"42","author":"Chauvineau-Grenier","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0027","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1093\/cid\/ciab1002","article-title":"Temporal dynamics of anti-type 1 interferon autoantibodies in patients with coronavirus disease 2019","volume":"75","author":"Shaw","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.011_bib0028","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/cells10123592","article-title":"New onset of autoimmune diseases following COVID-19 diagnosis","volume":"10","author":"Gracia-Ramos","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijid.2023.03.011_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705772","article-title":"SARS-CoV-2 proteome harbors peptides which are able to trigger autoimmunity responses: implications for infection, vaccination, and population coverage","volume":"12","author":"Karami Fath","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2023.03.011_bib0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J Hepatol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:11:16Z","timestamp":1761120676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"alternative-id":["S1201971223000875"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.03.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}